MAPT and Alzheimer disease: Transgenic AD mice studies expressing Aβ plaques in 5xFAD mice and Aβ plaques and tau in 3xTg mice [45] may be useful in longitudinal PET studies to study alterations in α7 nAChRs in transgenic mice models [46,47].